MENA: Market for Other Medicaments For Therapeutic Or Prophylactic Uses 2025

Market Size for Other Medicaments For Therapeutic Or Prophylactic Uses in MENA

The MENA's market for other medicaments for therapeutic or prophylactic uses rose rapidly to $X in 2022, surging by X% against the previous year. The market value increased at an average annual rate of X% over the period from 2012 to 2022; however, the trend pattern indicated some noticeable fluctuations being recorded in certain years. As a result, consumption attained the peak level of $X. From 2016 to 2022, the growth of the market remained at a somewhat lower figure.

Production of Other Medicaments For Therapeutic Or Prophylactic Uses in MENA

In value terms, production of other medicaments for therapeutic or prophylactic uses reduced to $X in 2022 estimated in export price. Overall, production, however, showed a abrupt curtailment. The pace of growth was the most pronounced in 2017 with an increase of X%. As a result, production attained the peak level of $X. From 2018 to 2022, production of growth failed to regain momentum.

Exports of Other Medicaments For Therapeutic Or Prophylactic Uses

Exports in MENA

In 2022, shipments abroad of other medicaments for therapeutic or prophylactic uses increased by X% to X tons, rising for the second year in a row after three years of decline. Overall, exports, however, saw a abrupt downturn. The volume of export peaked at X tons in 2017; however, from 2018 to 2022, the exports failed to regain momentum.

In value terms, exports of other medicaments for therapeutic or prophylactic uses skyrocketed to $X in 2022. In general, exports, however, recorded a pronounced decrease. The level of export peaked at $X in 2017; however, from 2018 to 2022, the exports remained at a lower figure.

Exports by Country

Israel dominates uses structure, accounting for X tons, which was near X% of total exports in 2022. It was distantly followed by Jordan (X tons), generating a X% share of total exports. Turkey (X tons) and Egypt (X tons) followed a long way behind the leaders.

From 2012 to 2022, average annual rates of growth with regard to other medicaments for therapeutic or prophylactic uses exports from Israel stood at X%. At the same time, Turkey (X%) displayed positive paces of growth. Moreover, Turkey emerged as the fastest-growing exporter exported in MENA, with a CAGR of X% from 2012-2022. By contrast, Egypt (X%) and Jordan (X%) illustrated a downward trend over the same period. Turkey (X p.p.) and Israel (X p.p.) significantly strengthened its position in terms of the total exports, while Jordan saw its share reduced by X% from 2012 to 2022, respectively. The shares of the other countries remained relatively stable throughout the analyzed period.

In value terms, Israel ($X) remains the largest other medicaments for therapeutic or prophylactic uses supplier in MENA, comprising X% of total exports. The second position in the ranking was held by Jordan ($X), with a X% share of total exports. It was followed by Turkey, with a X% share.

In Israel, exports of other medicaments for therapeutic or prophylactic uses contracted by an average annual rate of X% over the period from 2012-2022. The remaining exporting countries recorded the following average annual rates of exports growth: Jordan (X% per year) and Turkey (X% per year).

Export Prices by Country

In 2022, the export price in MENA amounted to $X per ton, jumping by X% against the previous year. Export price indicated a notable expansion from 2012 to 2022: its price increased at an average annual rate of X% over the last decade. The trend pattern, however, indicated some noticeable fluctuations being recorded throughout the analyzed period. Based on 2022 figures, export price for other medicaments for therapeutic or prophylactic uses increased by X% against 2020 indices. The most prominent rate of growth was recorded in 2021 an increase of X% against the previous year. Over the period under review, the export prices reached the maximum in 2022 and is expected to retain growth in the immediate term.

Prices varied noticeably by country of origin: amid the top suppliers, the country with the highest price was Israel ($X per ton), while Egypt ($X per ton) was amongst the lowest.

From 2012 to 2022, the most notable rate of growth in terms of prices was attained by Jordan (X%), while the other leaders experienced mixed trends in the export price figures.

Imports of Other Medicaments For Therapeutic Or Prophylactic Uses

Imports in MENA

In 2022, supplies from abroad of other medicaments for therapeutic or prophylactic uses increased by X% to X tons, rising for the second consecutive year after two years of decline. Over the period under review, imports, however, recorded a pronounced shrinkage. The growth pace was the most rapid in 2017 with an increase of X%. The volume of import peaked at X tons in 2013; however, from 2014 to 2022, imports failed to regain momentum.

In value terms, imports of other medicaments for therapeutic or prophylactic uses reduced modestly to $X in 2022. The total import value increased at an average annual rate of X% from 2012 to 2022; however, the trend pattern indicated some noticeable fluctuations being recorded throughout the analyzed period. The growth pace was the most rapid in 2021 when imports increased by X% against the previous year. The level of import peaked at $X in 2019; however, from 2020 to 2022, imports stood at a somewhat lower figure.

Imports by Country

In 2022, Turkey (X tons), Tunisia (X tons), Algeria (X tons) and Egypt (X tons) represented the key importer of other medicaments for therapeutic or prophylactic uses in MENA, achieving X% of total import. Saudi Arabia (X tons) ranks next in terms of the total imports with a X% share, followed by Iran (X%) and the United Arab Emirates (X%). Israel (X tons), Yemen (X tons), Iraq (X tons), Morocco (X tons), Jordan (X tons) and Kuwait (X tons) followed a long way behind the leaders.

From 2012 to 2022, the biggest increases were recorded for Turkey (with a CAGR of X%), while purchases for the other leaders experienced more modest paces of growth.

In value terms, Tunisia ($X), Algeria ($X) and Turkey ($X) were the countries with the highest levels of imports in 2022, together accounting for X% of total imports. Saudi Arabia, Iran, Egypt, the United Arab Emirates, Israel, Iraq, Jordan, Morocco, Yemen and Kuwait lagged somewhat behind, together accounting for a further X%.

Egypt, with a CAGR of X%, recorded the highest growth rate of the value of imports, in terms of the main importing countries over the period under review, while purchases for the other leaders experienced more modest paces of growth.

Import Prices by Country

In 2022, the import price in MENA amounted to $X per ton, approximately equating the previous year. Import price indicated resilient growth from 2012 to 2022: its price increased at an average annual rate of X% over the last decade. The trend pattern, however, indicated some noticeable fluctuations being recorded throughout the analyzed period. Based on 2022 figures, import price for other medicaments for therapeutic or prophylactic uses increased by X% against 2016 indices. The most prominent rate of growth was recorded in 2021 an increase of X%. As a result, import price reached the peak level of $X per ton, leveling off in the following year.

Prices varied noticeably by country of destination: amid the top importers, the country with the highest price was Tunisia ($X per ton), while Yemen ($X per ton) was amongst the lowest.

From 2012 to 2022, the most notable rate of growth in terms of prices was attained by Tunisia (X%), while the other leaders experienced more modest paces of growth.

Source: IndexBox Platform